Arachidonoyl serotonin

Arachidonoyl serotonin
Arachidonoyl serotonin
Identifiers
CAS number 187947-37-1 YesY
Jmol-3D images Image 1
Properties
Molecular formula C30H42N2O2
Molar mass 462.67 g mol−1
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Arachidonoyl serotonin (N-arachidonoyl-serotonin, AA-5-HT) is an endogenous lipid signaling molecule. It was first described in 1998 as being an inhibitor of fatty acid amide hydrolase (FAAH).[1] In 2007, it was shown to have analgesic properties and to act as an antagonist of the TRPV1 receptor.[2] In 2011, it was shown to be present in the ileum and jejunum of the gastrointestinal tract and modulate glucagon-like peptide-1 (GLP-1) secretion.[3]

References

  1. ^ Bisogno, T.; Melck, D.; De Petrocellis, L.; Bobrov, M. U.; Gretskaya, N. M.; Bezuglov, V. V.; Sitachitta, N.; Gerwick, W. H. et al. (1998). "Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase". Biochemical and biophysical research communications 248 (3): 515–522. PMID 9703957.  edit
  2. ^ Maione, S.; Petrocellis, L.; Novellis, V.; Moriello, A. S.; Petrosino, S.; Palazzo, E.; Rossi, F. S.; Woodward, D. F. et al. (2007). "Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors". British Journal of Pharmacology 150 (6): 766–781. doi:10.1038/sj.bjp.0707145. PMC 2013858. PMID 17279090. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2013858.  edit
  3. ^ Verhoeckx, K. C. M.; Voortman, T.; Balvers, M. G. J.; Hendriks, H. F. J.; m.Wortelboer, H.; Witkamp, R. F. (2011). "Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1811 (10): 578–586. doi:10.1016/j.bbalip.2011.07.008. PMID 21798367.  edit

Wikimedia Foundation. 2010.

Игры ⚽ Нужно решить контрольную?

Look at other dictionaries:

  • N-Arachidonoyl dopamine — IUPAC name (5Z,8Z,11Z,14Z) N [2 (3,4 dihydroxyphenyl) ethyl]icosa 5,8,11,14 tetraenamide …   Wikipedia

  • Cannabinoid receptor antagonist — The discovery of the endogenous cannabinoid system led to the development of CB1 receptor antagonists. The first cannabinoid receptor antagonist, rimonabant, was described in 1994. Rimonabant blocks the CB1 receptor selectively and it has been… …   Wikipedia

  • AM404 — Systematic (IUPAC) name (5Z,8Z,11Z,14Z) N (4 hydroxyphenyl)icosa 5,8,11,14 tetraenamide Clinical data Pregnancy cat …   Wikipedia

  • Anandamide — IUPAC name (5Z,8Z,11Z,14Z) N (2 hydroxyethyl)icosa 5,8,11,14 tetraenamide …   Wikipedia

  • Virodhamine — IUPAC name 2 aminoethyl (5Z,8Z,11Z,14Z) icosa 5,8,11,14 tetraenoate …   Wikipedia

  • Oleamide — Oleamide[1] IUPAC name (Z) Octa 9 decenami …   Wikipedia

  • 2-Arachidonyl glyceryl ether — IUPAC name 2 [(5Z,8Z,11Z,14Z) 5,8,11,14 Icosatetraen 1 yloxy] 1,3 propanediol …   Wikipedia

  • Tetrahydrocannabinol — THC redirects here. For other uses, see THC (disambiguation). Tetrahydrocannabinol (THC) …   Wikipedia

  • Paracetamol — Acetaminophen Systematic (IUPAC) name …   Wikipedia

  • Effects of cannabis — Short term effects of cannabis Classification and external resources ICD 10 F12.0 The effects of cannabis are caused by cannabinoids, most notably tetrahydrocannabinol (THC). Cannabis has both psychological and physiological effects on the human… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”